{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:45:10Z","timestamp":1757619910956,"version":"3.44.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01279-9","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T10:04:29Z","timestamp":1753697069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does a take-home dose program result in better patient adherence to methadone? Evidence from Vietnam"],"prefix":"10.1186","volume":"22","author":[{"given":"Thuong","family":"Nong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Hodgkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Bich","family":"Diep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Capoccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoang Dinh","family":"Canh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"1279_CR1","unstructured":"UNODC. The Challenge of Synthetic Drugs in East and South-East Asia [Internet]. 2017 [cited 2023 Nov 12]. Available from: https:\/\/www.unodc.org\/documents\/scientific\/Trends_and_Patterns_of_ATS_and_NPS_2017.pdf"},{"key":"1279_CR2","unstructured":"Ministry of Health. The annual report of HIV\/AIDS in 2011. Hanoi, Vietnam. 2012. 2012."},{"key":"1279_CR3","unstructured":"SAMHSA. Medication-Assisted Treatment (MAT)| SAMHSA [Internet]. 2020. Available from: https:\/\/www.samhsa.gov\/medication-assisted-treatment"},{"key":"1279_CR4","unstructured":"VAAC. Vietnam Administration of HIV\/AIDS Control - Report for 2022. 2023 Jan 14 [cited 2023 Nov 12]; Available from: https:\/\/www.file:\/\/\/C:\/Users\/succe\/Zotero\/storage\/CVGPYLDD\/cuc-phong-chong-hiv-aids-to-chuc-hoi-nghi-to-ng-ke-t-cong-ta-c-pho-ng-cho-ng-hiv-aids-nam-2022.html"},{"key":"1279_CR5","unstructured":"FHI 360. Effectiveness Evaluation of the Pilot Program for Treatment of Opioid Dependence with Methadone| FHI 360 [Internet]. 2014. Available from: https:\/\/www.fhi360.org\/resource\/effectiveness-evaluation-pilot-program-treatment-opioid-dependence-methadone"},{"issue":"1","key":"1279_CR6","first-page":"1","volume":"12","author":"LH Nguyen","year":"2017","unstructured":"Nguyen LH, Nguyen HTT, Nguyen HLT, Tran BX, Latkin CA. Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas. Subst Abuse: Treat Prev Policy. 2017;12(1):1\u20139.","journal-title":"Subst Abuse: Treat Prev Policy"},{"key":"1279_CR7","doi-asserted-by":"crossref","unstructured":"Le TA, Ha GH, Le MQT, Tran LMH, Pham DTT, Tran NHT et al. Treatment adherence amongst drug users attending public and private methadone maintenance clinics in a northern province of Vietnam. Substance abuse treatment, prevention, and policy [Internet]. 2020;15(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32345318\/","DOI":"10.1186\/s13011-020-00271-9"},{"issue":"1","key":"1279_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12954-024-01040-8","volume":"21","author":"HTT Nguyen","year":"2024","unstructured":"Nguyen HTT, Dinh DX. Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam. Harm Reduct J. 2024;21(1):129.","journal-title":"Harm Reduct J"},{"key":"1279_CR9","unstructured":"McGrath E. Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics. Drugnet Irel. 2021;Issue 77, Spring 2021:37\u20138."},{"issue":"1","key":"1279_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12954-017-0185-7","volume":"14","author":"PM Khue","year":"2017","unstructured":"Khue PM, Tham NT, Thanh Mai DT, Thuc PV, Thuc VM, Han PV, et al. A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in haiphong, Vietnam. Harm Reduct J. 2017;14(1):59.","journal-title":"Harm Reduct J"},{"key":"1279_CR11","doi-asserted-by":"publisher","unstructured":"Johns B, Chau LB, Hanh KH, Manh PD, Do HM, Duong AT et al. Association Between User Fees and Dropout from Methadone Maintenance Therapy: Results of a Cohort Study in Vietnam. 2018;4(2):101\u2013113. https:\/\/doi.org\/10.1080\/23288604.2018.1440347","DOI":"10.1080\/23288604.2018.1440347"},{"key":"1279_CR12","doi-asserted-by":"crossref","unstructured":"Kiriazova T, Go VF, Hershow RB, Hamilton EL, Sarasvita R, Bui Q et al. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study. Harm Reduct J [Internet]. 2020;17(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32998731\/","DOI":"10.1186\/s12954-020-00415-x"},{"key":"1279_CR13","doi-asserted-by":"crossref","unstructured":"Tran BX, Nguyen LH, Tran TT, Latkin CA. Social and structural barriers for adherence to methadone maintenance treatment among Vietnamese opioid dependence patients. PloS one [Internet]. 2018;13(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29346444\/","DOI":"10.1371\/journal.pone.0190941"},{"key":"1279_CR14","doi-asserted-by":"crossref","unstructured":"Newman RG. Take-home \u201cprivileges\u201c for methadone maintenance patients: policies versus practices. J Addict Med. 2012;6(4):318\u2013318.","DOI":"10.1097\/ADM.0b013e31826d93b5"},{"issue":"2","key":"1279_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/ADM.0b013e3181e6ad48","volume":"5","author":"E Peles","year":"2011","unstructured":"Peles E, Schreibe S, Sason A, Adelson M. Earning Take-Home privileges and long-term outcome in a methadone maintenance treatment program. J Addict Med. 2011;5(2):92\u20138.","journal-title":"J Addict Med"},{"issue":"1","key":"1279_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"D Frank","year":"2021","unstructured":"Frank D, Mateu-Gelabert P, Perlman DC, Walters SM, Curran L, Guarino H. It\u2019s like \u2018liquid handcuffs: the effects of take-home dosing policies on methadone maintenance treatment (MMT) patients\u2019 lives. Harm Reduct J. 2021;18(1):1\u201310.","journal-title":"Harm Reduct J"},{"issue":"2","key":"1279_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","volume":"35","author":"G Gerra","year":"2011","unstructured":"Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, et al. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):483\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"1279_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0740-5472(97)00318-8","volume":"16","author":"MA Chutuape","year":"1999","unstructured":"Chutuape MA, Silverman K, Stitzer ML. Use of methadone Take-Home contingencies with persistent opiate and cocaine abusers. J Subst Abuse Treat. 1999;16(1):23\u201330.","journal-title":"J Subst Abuse Treat"},{"key":"1279_CR19","doi-asserted-by":"publisher","first-page":"102901","DOI":"10.1016\/j.drugpo.2020.102901","volume":"83","author":"B del Pozo","year":"2020","unstructured":"del Pozo B, Beletsky L. No back to normal after COVID-19 for our failed drug policies. Int J Drug Policy. 2020;83:102901.","journal-title":"Int J Drug Policy"},{"issue":"9","key":"1279_CR20","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s10461-020-02887-1","volume":"24","author":"KM Peavy","year":"2020","unstructured":"Peavy KM, Darnton J, Grekin P, Russo M, Green CJB, Merrill JO, et al. Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at High-Risk for HIV in an opioid treatment program. AIDS Behav. 2020;24(9):2469\u201372.","journal-title":"AIDS Behav"},{"key":"1279_CR21","doi-asserted-by":"publisher","unstructured":"Levander XA, Hoffman KA, Mcilveen JW, Mccarty D, Terashima JP, Korthuis PT. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis. Available from: https:\/\/doi.org\/10.1186\/s13722-021-00281-3","DOI":"10.1186\/s13722-021-00281-3"},{"issue":"1","key":"1279_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-021-00281-3","volume":"16","author":"XA Levander","year":"2021","unstructured":"Levander XA, Hoffman KA, McIlveen JW, McCarty D, Terashima JP, Korthuis PT. Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis. Addict Sci Clin Pract. 2021;16(1):1\u201310.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"1279_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/08897077.2021.1986768","volume":"43","author":"XA Levander","year":"2022","unstructured":"Levander XA, Pytell JD, Stoller KB, Korthuis PT, Chander G. COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership. Substance Abuse. 2022;43(1):633\u20139.","journal-title":"Substance Abuse"},{"issue":"6","key":"1279_CR24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/00952990.2021.1979991","volume":"47","author":"O Amram","year":"2021","unstructured":"Amram O, Amiri S, Panwala V, Lutz R, Joudrey PJ, Socias E. The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era. Am J Drug Alcohol Abus. 2021;47(6):722\u20139.","journal-title":"Am J Drug Alcohol Abus"},{"key":"1279_CR25","doi-asserted-by":"crossref","unstructured":"Hossain MB, Guerra-Alejos BC, Kurz M, Min JE, Karim ME, Seaman S et al. Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelines. 2025 Mar 1 [cited 2025 May 18]; Available from: https:\/\/bmjopen.bmj.com\/content\/15\/3\/e095198","DOI":"10.1136\/bmjopen-2024-095198"},{"issue":"3","key":"1279_CR26","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/ADM.0b013e3182584772","volume":"6","author":"AY Walley","year":"2012","unstructured":"Walley AY, Cheng DM, Pierce CE, Chen C, Filippell T, Samet JH, et al. Methadone dose, take home status, and hospital admission among methadone maintenance patients. J Addict Med. 2012;6(3):186\u201390.","journal-title":"J Addict Med"},{"issue":"1","key":"1279_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2137284","volume":"36","author":"RM Andersen","year":"1995","unstructured":"Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1\u201310.","journal-title":"J Health Soc Behav"},{"key":"1279_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2147\/RMHP.S218661","volume":"12","author":"S Zhang","year":"2019","unstructured":"Zhang S, Chen Q, Zhang B. Understanding healthcare utilization in China through the andersen behavioral model: review of evidence from the China health and nutrition survey. Risk Manag Healthc Policy. 2019;12:209\u201324.","journal-title":"Risk Manag Healthc Policy"},{"issue":"4","key":"1279_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/ADM.0000000000000402","volume":"12","author":"A Acevedo","year":"2018","unstructured":"Acevedo A. Improving quality of care for SUDS: where do we go from here? J Addict Med. 2018;12(4):257\u20138.","journal-title":"J Addict Med"},{"issue":"4","key":"1279_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0306624X10366012","volume":"55","author":"CB Oser","year":"2011","unstructured":"Oser CB, Leukefeld CG, Staton Tindall M, Garrity TF, Carlson RG, Falck R, et al. Rural drug users: factors associated with substance abuse treatment utilization. Int J Offender Ther Comp Criminol. 2011;55(4):567\u2013567.","journal-title":"Int J Offender Ther Comp Criminol"},{"key":"1279_CR31","doi-asserted-by":"crossref","unstructured":"Pinedo M, Villatoro AP. The role of perceived treatment need in explaining racial\/ethnic disparities in the use of substance abuse treatment services. Journal of substance abuse treatment [Internet]. 2020;118. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32839050\/","DOI":"10.1016\/j.jsat.2020.108105"},{"key":"1279_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","volume":"169","author":"LT Wu","year":"2016","unstructured":"Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the united States. Drug Alcohol Depend. 2016;169:117\u2013117.","journal-title":"Drug Alcohol Depend"},{"key":"1279_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.drugalcdep.2017.03.037","volume":"177","author":"LT Wu","year":"2017","unstructured":"Wu LT, Zhu H, Mannelli P, Swartz MS. Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the united States. Drug Alcohol Depend. 2017;177:153\u201362.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1279_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cct.2006.05.007","volume":"28","author":"MA Hussey","year":"2007","unstructured":"Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182\u201391.","journal-title":"Contemp Clin Trials"},{"key":"1279_CR35","doi-asserted-by":"publisher","unstructured":"A comparison of statistical. methods for modeling count data with an application to hospital length of stay| BMC Medical Research Methodology| Full Text [Internet]. [cited 2025 Jun 1]. Available from: https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12874-022-01685-8","DOI":"10.1186\/s12874-022-01685-8"},{"key":"1279_CR36","volume-title":"Stata statistical software: release 18. College station","author":"StataCorp","year":"2023","unstructured":"StataCorp. Stata statistical software: release 18. College station. TX: StataCorp LLC; 2023."},{"key":"1279_CR37","doi-asserted-by":"crossref","unstructured":"Williams AR, Krawczyk N, Hu MC, Harpel L, Aydinoglo N, Cerda M et al. Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study. The Lancet Regional Health \u2013 Americas [Internet]. 2023 Dec 1 [cited 2023 Dec 17];28. Available from: https:\/\/www.thelancet.com\/journals\/lanam\/article\/PIIS2667-193X(23)00210-7\/fulltext","DOI":"10.1016\/j.lana.2023.100636"},{"key":"1279_CR38","doi-asserted-by":"publisher","first-page":"108449","DOI":"10.1016\/j.jsat.2021.108449","volume":"131","author":"S Brothers","year":"2021","unstructured":"Brothers S, Viera A, Heimer R. Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. J Subst Abuse Treat. 2021;131:108449.","journal-title":"J Subst Abuse Treat"},{"key":"1279_CR39","doi-asserted-by":"crossref","unstructured":"Hoffman KA, Foot C, Levander XA, Cook R, Terashima JP, McIlveen JW et al. Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis. J Subst Abuse Treat. 2022;108801\u2013108801.","DOI":"10.1016\/j.jsat.2022.108801"},{"key":"1279_CR40","unstructured":"VHATTC. Take-home dose Methadone program in the context of COVID-19 pandemic in Ho Chi Minh City, Vietnam \u2013 Trung t\u00e2m chuy\u1ec3n giao c\u00f4ng ngh\u1ec7 \u0111i\u1ec7u tr\u1ecb nghi\u1ec7n ch\u1ea5t v\u00e0 HIV [Internet]. Available from: https:\/\/svhattc.org\/take-home-dose-methadone-program-in-the-context-of-covid-19-pandemic-in-ho-chi-minh-city-vietnam\/?lang=en"},{"key":"1279_CR41","doi-asserted-by":"crossref","unstructured":"Le UTN, Tran TT, Le GT, Thai TT. Methadone maintenance treatment in Ho Chi Minh City, Vietnam: Multidimensional measure of adherence and associated factors. Global public health [Internet]. 2020; Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33342367\/","DOI":"10.1080\/17441692.2020.1864750"},{"key":"1279_CR42","doi-asserted-by":"crossref","unstructured":"Dao TMA, Nguyen TTH, Nguyen HL. Variation Overtime among Patients of the Six Methadone Maintenance Treatment Clinics in Thai Nguyen from 2011 to 2015. BioMed Research International [Internet]. 2018;2018. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6106799\/","DOI":"10.1155\/2018\/9081968"},{"issue":"1","key":"1279_CR43","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13722-022-00289-3","volume":"17","author":"B Myers","year":"2022","unstructured":"Myers B, Koch JR, Johnson K, Harker N. Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in cape town, South Africa. Addict Sci Clin Pract. 2022;17(1):8.","journal-title":"Addict Sci Clin Pract"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01279-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01279-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:26:30Z","timestamp":1757305590000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01279-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01279-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Brandeis University Institutional Review Board reviewed and approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}